Status:
COMPLETED
A Study Evaluating Efficacy and Safety of YM150 Compared to Enoxaparin in Subjects Undergoing Hip Replacement Surgery
Lead Sponsor:
Astellas Pharma Europe B.V.
Conditions:
Venous Thromboembolism
Arthroplasty, Replacement, Hip
Eligibility:
All Genders
18+ years
Phase:
PHASE2
PHASE3
Brief Summary
The purpose of this study is to evaluate the efficacy and safety of various doses of YM150 (the experimental drug) compared to enoxaparin in the prevention of venous thromboembolism in patients that a...
Eligibility Criteria
Inclusion
- Subject is scheduled for elective hip replacement surgery
Exclusion
- Subject has active bleeding or any condition associated with increased risk of bleeding
- Subject has had major trauma or surgery within 3 months before planned hip replacement surgery or requires major surgery or other invasive procedures with potential for uncontrolled bleeding during the study
- Subject has had an MI or stroke within 3 months before planned hip replacement surgery
Key Trial Info
Start Date :
April 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2010
Estimated Enrollment :
1992 Patients enrolled
Trial Details
Trial ID
NCT00902928
Start Date
April 1 2009
End Date
August 1 2010
Last Update
October 27 2015
Active Locations (156)
Enter a location and click search to find clinical trials sorted by distance.
1
Phoenix, Arizona, United States, 85023
2
Phoenix, Arizona, United States, 85050
3
Tuscon, Arizona, United States, 85712
4
Little Rock, Arkansas, United States, 72205